Waldron Private Wealth LLC Has $314,000 Stock Holdings in Elevance Health, Inc. (NYSE:ELV)

Waldron Private Wealth LLC lessened its stake in Elevance Health, Inc. (NYSE:ELV) by 25.5% during the 4th quarter, Holdings Channel reports. The institutional investor owned 852 shares of the company’s stock after selling 291 shares during the quarter. Waldron Private Wealth LLC’s holdings in Elevance Health were worth $314,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Raelipskie Partnership acquired a new position in Elevance Health in the 3rd quarter valued at approximately $26,000. PSI Advisors LLC acquired a new position in Elevance Health in the 3rd quarter valued at approximately $27,000. Eastern Bank acquired a new position in Elevance Health in the 3rd quarter valued at approximately $31,000. Dunhill Financial LLC increased its stake in Elevance Health by 57.8% in the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock valued at $37,000 after buying an additional 26 shares during the period. Finally, Peterson Financial Group Inc. acquired a new position in Elevance Health in the 3rd quarter valued at approximately $44,000. Institutional investors and hedge funds own 89.24% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on ELV. UBS Group dropped their price objective on shares of Elevance Health from $605.00 to $555.00 and set a “buy” rating on the stock in a research note on Friday, October 18th. Royal Bank of Canada decreased their target price on shares of Elevance Health from $585.00 to $478.00 and set an “outperform” rating for the company in a research report on Friday, October 18th. Morgan Stanley decreased their target price on shares of Elevance Health from $643.00 to $551.00 and set an “overweight” rating for the company in a research report on Wednesday, October 23rd. StockNews.com downgraded shares of Elevance Health from a “buy” rating to a “hold” rating in a research report on Monday, January 27th. Finally, Wells Fargo & Company decreased their target price on shares of Elevance Health from $483.00 to $478.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Four analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $517.03.

Elevance Health Price Performance

Shares of Elevance Health stock opened at $395.82 on Monday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.45 and a quick ratio of 1.50. Elevance Health, Inc. has a fifty-two week low of $362.21 and a fifty-two week high of $567.26. The firm has a fifty day moving average price of $386.50 and a two-hundred day moving average price of $457.14. The company has a market cap of $91.80 billion, a PE ratio of 15.46, a price-to-earnings-growth ratio of 1.20 and a beta of 0.84.

Elevance Health (NYSE:ELV) last issued its quarterly earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share for the quarter, beating analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%. Analysts expect that Elevance Health, Inc. will post 34.09 EPS for the current year.

Elevance Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be paid a $1.71 dividend. This is a boost from Elevance Health’s previous quarterly dividend of $1.63. The ex-dividend date of this dividend is Monday, March 10th. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.73%. Elevance Health’s dividend payout ratio is currently 26.71%.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.